ASX-listed Aroa Biosurgery gains on positive outlook

Aroa Biosurgery

28/11/2023 24:37

** Shares of Aroa Biosurgery  ARX.AX  rise as much as 8.3%
to A$0.780, their highest level since Nov. 10
    ** Soft-tissue regeneration co sees H2 FY24 product revenue
of NZ$41 mln ($25.01 mln)-NZ$44 mln, representing a 30%-40%
increase on H1 FY24
    ** Sees H2 FY24 normalised EBITDA profit of NZ$4-5 million,
compared to a NZ$2.7 mln loss in H1 FY24
    ** Stock down 33.3% YTD, as of last close
 


($1 = 1.6393 New Zealand dollars)

 (Reporting by Ayushman Ojha in Bengaluru)
 ((Ayushman.ojha@thomsonreuters.com;))